(Q44376610)

2 December 2017

title

An audit of clinical service examining the uptake of genetic testing by at-risk family members (English)

1 reference

2 December 2017

2

Martin Delatycki

1 reference

2 December 2017

Laura Forrest

1

1 reference

2 December 2017

Lisette Curnow

3

1 reference

2 December 2017

M Gen Couns

4

1 reference

2 December 2017

Loane Skene

5

1 reference

2 December 2017

Maryanne Aitken

6

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

2 December 2017

1 reference

2 December 2017

volume

14

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

122-128

1 reference

https://scigraph.springernature.com/pub.10.1038/gim.2011.3

2 December 2017

exact match

0 references

cites work

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Impact of genetic testing for Huntington disease on the family system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Statistical analysis of correlated data using generalized estimating equations: an orientation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Effect of family history on disclosure patterns of cystic fibrosis carrier status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

DNA testing for fragile X syndrome: implications for parents and family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Experiences of genetic risk: disclosure and the gendering of responsibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

The FMR1 premutation and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Prevalence of SMN1 deletion and duplication in carrier and normal populations: implication for genetic counselling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Problems assessing uptake of Huntington disease predictive testing and a proposed solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Fifteen years of experience in predictive testing for Huntington disease at a single testing center in Victoria, Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

To tell or not to tell: barriers and facilitators in family communication about genetic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

Predictive testing for Huntington's disease: II. Qualitative findings from a study of uptake in South Wales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

7 January 2021

Predictive testing for Huntington's disease: I. Predictors of uptake in South Wales.

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

7 January 2021

Uptake of testing for BRCA1/2 mutations in South East Scotland

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

7 January 2021

Increased genetic counseling support improves communication of genetic information in families

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

7 January 2021

Population screening and cascade testing for carriers of SMA

1 reference

https://api.crossref.org/works/10.1038%2FGIM.2011.3

7 January 2021

Identifiers

DOI

10.1038/GIM.2011.3

1 reference

2 December 2017

1 reference